Exelixis
EXEL
#1888
Rank
NZ$18.80 B
Marketcap
NZ$74.03
Share price
-1.75%
Change (1 day)
11.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company